Literature DB >> 25603804

Endothelial Cell Inflammation and Antioxidant Capacity are Associated With Exercise Performance and Microcirculation in Patients With Symptomatic Peripheral Artery Disease.

Andrew W Gardner1, Donald E Parker2, Polly S Montgomery3, Danuta Sosnowska3, Ana I Casanegra4, Zoltan Ungvari3, Anna Csiszar3, William E Sonntag3.   

Abstract

We determined whether exercise performance and lower extremity microcirculation were associated with endothelial cell inflammation, oxidative stress, and apoptosis and with circulating biomarkers of inflammation and antioxidant capacity in 160 patients with symptomatic peripheral artery disease (PAD). In a multivariate regression model for peak walking time, significant independent variables included ankle-brachial index (P < .001), age (P = .017), hydroxyl radical antioxidant capacity (P = .008), and endothelial cell nuclear factor K-light-chain-enhancer of activated B cells (NF-κB) activity (P = .015). In multivariate analyses for time to minimum exercise calf muscle hemoglobin oxygen saturation (StO2), significant independent variables included endothelial cell NF-κB activity (P = .043) and calf muscle StO2 at rest (P = .007). Endothelial cell inflammation and circulating biomarkers of inflammation and antioxidant capacity were associated with exercise performance and microcirculation of the ischemic calf musculature during exercise. The clinical implication is that interventions designed to alleviate endothelial cell inflammation and circulating inflammatory biomarkers, such as antioxidant therapy, may improve exercise performance of symptomatic patients with PAD.
© The Author(s) 2015.

Entities:  

Keywords:  antioxidant capacity; claudication; inflammation; peripheral artery disease

Mesh:

Substances:

Year:  2015        PMID: 25603804      PMCID: PMC6004125          DOI: 10.1177/0003319714566863

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  45 in total

1.  National health care costs of peripheral arterial disease in the Medicare population.

Authors:  Alan T Hirsch; Lacey Hartman; Robert J Town; Beth A Virnig
Journal:  Vasc Med       Date:  2008-08       Impact factor: 3.239

2.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

3.  Peripheral arterial disease assessment with photoplethysmography and continuous-wave Doppler ultrasound in addition to ankle-brachial index may loss time and funds.

Authors:  Du Hyun Ro; Dong Yeon Lee; Hyuk Ju Moon; Ji Hyeung Kim; Kyoung Min Lee; Sung Ju Kim
Journal:  Angiology       Date:  2013-02-06       Impact factor: 3.619

4.  Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Omar L Esponda; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  Angiology       Date:  2013-09-03       Impact factor: 3.619

5.  Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease.

Authors:  A R Yataco; M C Corretti; A W Gardner; C J Womack; L I Katzel
Journal:  Am J Cardiol       Date:  1999-03-01       Impact factor: 2.778

6.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

7.  Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.

Authors:  Elizabeth M Mahoney; Kaijun Wang; Hong H Keo; Sue Duval; Kim G Smolderen; David J Cohen; Gabriel Steg; Deepak L Bhatt; Alan T Hirsch
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-12

8.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction.

Authors:  D S Celermajer; K E Sorensen; C Bull; J Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

9.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors:  Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

10.  Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Steve M Blevins; April M Teague; Ana I Casanegra
Journal:  Angiology       Date:  2013-05-21       Impact factor: 3.619

View more
  9 in total

1.  Association between gait characteristics and endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ana I Casanegra; Federico Silva-Palacios; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-06-06

2.  Changes in vascular and inflammatory biomarkers after exercise rehabilitation in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery
Journal:  J Vasc Surg       Date:  2019-03-25       Impact factor: 4.268

3.  Endothelial Cell Inflammation and Antioxidant Capacity are Associated With 6-Minute Walk Performance in Patients With Symptomatic Peripheral Artery Disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Yan D Zhao; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  Angiology       Date:  2017-08-24       Impact factor: 3.619

4.  Association between daily walking and antioxidant capacity in patients with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Yan D Zhao; Federico Silva-Palacios; Zoltan Ungvari; Anna Csiszar; William E Sonntag
Journal:  J Vasc Surg       Date:  2017-03-01       Impact factor: 4.268

5.  S100A8 and S100A9 are elevated in chronically threatened ischemic limb muscle and induce ischemic mitochondrial pathology in mice.

Authors:  Zachary R Salyers; Vinicius Mariani; Nicholas Balestrieri; Ravi A Kumar; Nicholas A Vugman; Trace Thome; Katelyn R Villani; Scott A Berceli; Salvatore T Scali; Georgios Vasilakos; Terence E Ryan
Journal:  JVS Vasc Sci       Date:  2022-04-21

6.  Physical Activity Levels in Peripheral Artery Disease Patients.

Authors:  Aline Mendes Gerage; Marilia de Almeida Correia; Paulo Mesquita Longano de Oliveira; Aline Cabral Palmeira; Wagner Jorge Ribeiro Domingues; Antônio Eduardo Zeratti; Pedro Puech-Leão; Nelson Wolosker; Raphael Mendes Ritti-Dias; Gabriel Grizzo Cucato
Journal:  Arq Bras Cardiol       Date:  2019-07-29       Impact factor: 2.000

7.  Acute effects of leg heat therapy on walking performance and cardiovascular and inflammatory responses to exercise in patients with peripheral artery disease.

Authors:  Jacob C Monroe; Qifan Song; Michael S Emery; Daniel M Hirai; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  Physiol Rep       Date:  2021-01

8.  INFLUENCE OF DIABETES ON AMBULATION AND INFLAMMATION IN MEN AND WOMEN WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE.

Authors:  Andrew W Gardner; Donald E Parker; Polly S Montgomery; Danuta Sosnowska; Ana I Casanegra; Zoltan Ungvari; Anna Csiszar; Sarah X Zhang; Josh J Wang; William E Sonntag
Journal:  J Clin Transl Endocrinol       Date:  2015-12-01

Review 9.  Peripheral artery disease, redox signaling, oxidative stress - Basic and clinical aspects.

Authors:  Sebastian Steven; Andreas Daiber; Jörn F Dopheide; Thomas Münzel; Christine Espinola-Klein
Journal:  Redox Biol       Date:  2017-04-13       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.